These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 12377186)

  • 1. HSV amplicon-mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia.
    Tolba KA; Bowers WJ; Eling DJ; Casey AE; Kipps TJ; Federoff HJ; Rosenblatt JD
    Mol Ther; 2002 Oct; 6(4):455-63. PubMed ID: 12377186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of herpes simplex virus-1 amplicon-based immunotherapy for chronic lymphocytic leukemia.
    Tolba KA; Bowers WJ; Hilchey SP; Halterman MW; Howard DF; Giuliano RE; Federoff HJ; Rosenblatt JD
    Blood; 2001 Jul; 98(2):287-95. PubMed ID: 11435295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
    Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
    Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous antileukemic immune response induced by chronic lymphocytic leukemia B cells expressing the CD40 ligand and interleukin 2 transgenes.
    Takahashi S; Rousseau RF; Yotnda P; Mei Z; Dotti G; Rill D; Hurwitz R; Marini F; Andreeff M; Brenner MK
    Hum Gene Ther; 2001 Apr; 12(6):659-70. PubMed ID: 11426465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transduction of CLL cells by CD40 ligand enhances an antigen-specific immune recognition by autologous T cells.
    Mayr C; Kofler DM; Büning H; Bund D; Hallek M; Wendtner CM
    Blood; 2005 Nov; 106(9):3223-6. PubMed ID: 16014560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD40 activation: potential for specific immunotherapy in B-CLL.
    von Bergwelt-Baildon M; Maecker B; Schultze J; Gribben JG
    Ann Oncol; 2004 Jun; 15(6):853-7. PubMed ID: 15151939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of preactivated autologous T lymphocytes on CD80, CD86 and CD95 expression by chronic lymphocytic leukemia B cells.
    Romano C; De Fanis U; Sellitto A; Dalla Mora L; Chiurazzi F; Giunta R; Rotoli B; Lucivero G
    Leuk Lymphoma; 2003 Nov; 44(11):1963-71. PubMed ID: 14738151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic lymphocytic leukemia B cells can express CD40 ligand and demonstrate T-cell type costimulatory capacity.
    Schattner EJ; Mascarenhas J; Reyfman I; Koshy M; Woo C; Friedman SM; Crow MK
    Blood; 1998 Apr; 91(8):2689-97. PubMed ID: 9531577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular transfer of CD40 and OX40 ligands to leukemic human B cells induces expansion of autologous tumor-reactive cytotoxic T lymphocytes.
    Biagi E; Dotti G; Yvon E; Lee E; Pule M; Vigouroux S; Gottschalk S; Popat U; Rousseau R; Brenner M
    Blood; 2005 Mar; 105(6):2436-42. PubMed ID: 15536147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential of gene transfer into primary B-CLL cells using recombinant virus vectors.
    Wendtner CM; Kofler DM; Mayr C; Bund D; Hallek M
    Leuk Lymphoma; 2004 May; 45(5):897-904. PubMed ID: 15291346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy.
    Krackhardt AM; Harig S; Witzens M; Broderick R; Barrett P; Gribben JG
    Blood; 2002 Jul; 100(1):167-73. PubMed ID: 12070023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bystander transfer of functional human CD40 ligand from gene-modified fibroblasts to B-chronic lymphocytic leukemia cells.
    Biagi E; Yvon E; Dotti G; Amrolia PJ; Takahashi S; Popat U; Marini F; Andreeff M; Brenner MK; Rousseau RF
    Hum Gene Ther; 2003 Apr; 14(6):545-59. PubMed ID: 12718765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity.
    Tolba KA; Bowers WJ; Muller J; Housekneckt V; Giuliano RE; Federoff HJ; Rosenblatt JD
    Cancer Res; 2002 Nov; 62(22):6545-51. PubMed ID: 12438249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative analysis of MVA-CD40L and MVA-TRICOM vectors for enhancing the immunogenicity of chronic lymphocytic leukemia (CLL) cells.
    Litzinger MT; Foon KA; Tsang KY; Schlom J; Palena C
    Leuk Res; 2010 Oct; 34(10):1351-7. PubMed ID: 20122733
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules.
    Van den Hove LE; Van Gool SW; Vandenberghe P; Bakkus M; Thielemans K; Boogaerts MA; Ceuppens JL
    Leukemia; 1997 Apr; 11(4):572-80. PubMed ID: 9096698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD1d is expressed on B-chronic lymphocytic leukemia cells and mediates alpha-galactosylceramide presentation to natural killer T lymphocytes.
    Fais F; Morabito F; Stelitano C; Callea V; Zanardi S; Scudeletti M; Varese P; Ciccone E; Grossi CE
    Int J Cancer; 2004 Apr; 109(3):402-11. PubMed ID: 14961579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
    Ranheim EA; Cantwell MJ; Kipps TJ
    Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential approach to immunotherapy of chronic lymphocytic leukemia (CLL): enhanced immunogenicity of CLL cells via infection with vectors encoding for multiple costimulatory molecules.
    Palena C; Foon KA; Panicali D; Yafal AG; Chinsangaram J; Hodge JW; Schlom J; Tsang KY
    Blood; 2005 Nov; 106(10):3515-23. PubMed ID: 16081691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-21 and CD40L signals from autologous T cells can induce antigen-independent proliferation of CLL cells.
    Pascutti MF; Jak M; Tromp JM; Derks IA; Remmerswaal EB; Thijssen R; van Attekum MH; van Bochove GG; Luijks DM; Pals ST; van Lier RA; Kater AP; van Oers MH; Eldering E
    Blood; 2013 Oct; 122(17):3010-9. PubMed ID: 24014238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B-cell chronic lymphocytic leukemia-derived dendritic cells stimulate allogeneic T-cell response and express chemokines involved in T-cell migration.
    Łuczyński W; Stasiak-Barmuta A; Piszcz J; Iłendo E; Kowalczuk O; Krawczuk-Rybak M
    Neoplasma; 2007; 54(6):527-35. PubMed ID: 17949237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.